John B. Landis, Ph.D. Joins SAB

Kalamazoo, MI (November 13, 2008) - NanoMed Pharmaceuticals, Inc. announced today that John B. Landis, Ph.D. has joined its Scientific Advisory Board.  Dr. Landis has 30 years of leadership experience in pharmaceutical research and development and has helped develop over 40 new medications, including Camptosar for colorectal cancer.  Recently, he served as Senior Vice President of Pharmaceutical Sciences at Schering-Plough where he led a global team of 1,400 scientists engaged in the development of pharmaceuticals.  Prior to joining Schering-Plough, Dr. Landis was Senior Vice President of Preclinical Development at Pharmacia where he led global functions for toxicology, drug metabolism, and pharmaceutical sciences.  He chaired the corporate committees responsible for the development of all oncology drugs at Pharmacia and all infectious disease drugs at Schering-Plough.  Dr. Landis received his bachelor's degree in chemistry from Kent State University and his Ph.D. in Analytical Chemistry from Purdue University.

In addition to Dr. Landis, key members serving on NanoMed's Scientific Advisory Board include:  Russell J. Mumper, Ph.D., NanoMed co-founder, the John A. McNeill Distinguished Professor in the Molecular Pharmaceutics Division in the School of Pharmacy, and the first Director of the Center for Nanotechnology in Drug Delivery at The University of North Carolina at Chapel Hill; Michael Jay, Ph.D., NanoMed co-founder and professor in the Molecular Pharmaceutics division at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy; J. Patrick McGovren, Ph.D., VP, Preclinical Development of ProNai Therapeutics, Inc. and former Research Director, Clinical Pharmacology, Medical Development at Pfizer, Inc.; Charles Bibart, Ph.D., former Group Vice President - Active Pharmaceutical Ingredients for Pharmacia Corporation; and Douglas R. Morton, Jr., Ph.D., former Group Vice President, Technology Acquisitions & Operations for Discovery Research in Pharmacia Corporation.